封面
市场调查报告书
商品编码
1345282

全球生命科学分析市场 - 市场规模、份额、成长分析:按组件(软体、服务)、按类型(报告、说明分析) - 产业预测 (2023-2030)

Global Life Science Analytics Market Size, Share, Growth Analysis, By Component(Software, and Services), By Type(Reporting, Descriptive) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2021年全球生命科学分析市场规模达83.6亿美元。预计2023年至2030年该市场将以7.7%的年复合成长率成长,从2022年的90亿美元成长到2030年的163亿美元。

该市场的主要成长促进因素包括电子健康记录、临床试验、基因组学、穿戴式装置和社群媒体等各种资讯来源的医疗资料量的增加。在挑战的同时,巨大的机会也随之出现,例如透过应用人工智慧和机器学习演算法来彻底改变药物研发和个人化医疗的潜力。医疗保健资料的可用性推动了生命科学领域对实证决策的需求,从而推动了全球生命科学分析市场的发展。儘管资料隐私和整合等挑战仍然存在,但该市场为利用分析彻底改变药物开发、患者照护和整体营运效率的组织提供了令人兴奋的机会。

现实世界资料(包括电子健康记录、穿戴式装置和社群媒体)的使用不断增加,正在推动对分析解决方案的需求。真实世界的资料为患者结果、治疗效果和人口健康提供了宝贵的见解,促进生命领域领域的证据驱动决策。

将人工智慧和机器学习演算法融入生命科学分析解决方案有可能重塑药物研发发现、优化临床试验和个体化医疗保健。这些技术透过熟练地分析大量资料集、识别模式和预测结果,为更有效和更有针对性的干预措施铺平了道路。

在生命科学分析中处理敏感的患者资料会引发资料隐私和安全问题。 GDPR 和 HIPAA 等严格法规在资料治理和病患保密方面为组织带来了障碍。

该报告审视了全球生命科学分析市场,并提供了市场概述,包括按成分、类型、地区和参与市场的公司概况分類的趋势。

目录

执行摘要

母市场分析

市场规模

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

关键市场洞察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 趋势分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 顶级投资分析
  • 关键成功要素
  • 竞争程度

市场动态及前景

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
  • 法规状况
  • 波特分析

全球生命科学分析市场(按组成部分)

  • 市场概况
  • 软体
  • 服务

全球生命科学分析市场,依类型

  • 市场概况
  • 报告
  • 说明分析
  • 预测分析
  • 规范性分析

全球生命科学分析市场(按地区)

  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

竞争形势

  • 主要企业简介
    • IQVIA Holdings Inc.
    • SAS Institute Inc.
    • Accenture plc
    • Cognizant Technology Solutions Corporation
    • IBM Corporation
    • Oracle Corporation
    • Microsoft Corporation
    • Optum, Inc.
    • SAP SE
    • EXLService Holdings, Inc.
    • PAREXEL International Corporation
    • SCIO Health Analytics
    • Wipro Limited
    • PricewaterhouseCoopers LLP
    • TIBCO Software Inc.
    • Take Solutions Limited
    • Mu Sigma Inc.
    • Genpact Limited
    • QuintilesIMS Holdings, Inc.
    • Palantir Technologies Inc.
简介目录
Product Code: SQMIG35G2143

The global market for Life Science Analytics was worth USD 8.36 billion in 2021 and is projected to expand from USD 9 billion in 2022 to USD 16.30 billion by 2030, with a CAGR of 7.7% during 2023-2030.

The key growth drivers for this market include the escalating volume of healthcare data from various sources like electronic health records, clinical trials, genomics, wearables, and social media. Amid challenges, significant opportunities arise, such as the potential transformation of drug discovery and personalized medicine through the application of AI and ML algorithms. The demand for evidence-based decision-making in the life sciences sector, driven by the availability of healthcare data, is propelling the global life science analytics market. While challenges like data privacy and integration persist, the market offers exciting chances for organizations to harness analytics for innovation in drug development, patient care, and overall operational efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Life Science Analytics Market Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Life Science Analytics Market Segmental Analysis Report

The global life science analytics market is segmented on the basis of component, type, and region. Based on component, the market is segmented into software, and services. In terms of type, the market is segmented into reporting, descriptive, predictive, and prescriptive. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Life Science Analytics Market Driver

Surging Uptake of Real-World Data

The increasing utilization of real-world data, encompassing electronic health records, wearables, and social media, is propelling the demand for analytics solutions. Real-world data furnishes valuable insights into patient outcomes, treatment efficacy, and population health, thereby facilitating evidence-driven decision-making within the life sciences sector.

Advancements in Artificial Intelligence (AI) and Machine Learning (ML)

The incorporation of AI and ML algorithms into life science analytics solutions holds the potential to reshape drug discovery, optimize clinical trials, and personalize medicine. These technologies adeptly analyze extensive data sets, recognize patterns, and forecast outcomes, paving the way for more effective and precise interventions.

Global Life Science Analytics Market Restraint

Data Privacy and Security Apprehensions

Navigating sensitive patient data in life science analytics raises concerns about data privacy and security. Stringent regulations like GDPR and HIPAA impose hurdles on organizations in terms of data governance and preserving patient confidentiality.

Shortage of Skilled Workforce

The scarcity of proficient data scientists and analysts well-versed in both life sciences and analytics presents a noteworthy challenge. Extracting meaningful insights from intricate healthcare data necessitates specialized knowledge, potentially limiting the seamless implementation of analytics solutions.

Trends in the Global Life Science Analytics Market

Rising Focus on Instantaneous Analytics: The sector is observing a shift towards real-time analytics, allowing entities to make prompt decisions and adapt to dynamic market scenarios. Real-time data amalgamation, processing, and analysis are becoming imperative for gaining a competitive advantage in areas like personalized medicine, patient monitoring, and supply chain optimization.

Prioritizing Value-Based Care: The growing uptake of value-based care models, which link reimbursement to patient outcomes, is fueling the demand for analytics solutions. Life science organizations are utilizing analytics to showcase the value and efficacy of their offerings, streamline patient care routes, and enhance health economics.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Life Science Analytics Market by Component
    • Market Overview
    • Software
    • and Services
  • Global Life Science Analytics Market by Type
    • Market Overview
    • Reporting
    • Descriptive
    • Predictive
    • and Prescriptive
  • Global Life Science Analytics Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • IQVIA Holdings Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SAS Institute Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Accenture plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cognizant Technology Solutions Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • IBM Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Oracle Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Microsoft Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Optum, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SAP SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • EXLService Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • PAREXEL International Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SCIO Health Analytics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Wipro Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • PricewaterhouseCoopers LLP (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • TIBCO Software Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Take Solutions Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mu Sigma Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Genpact Limited (Bermuda)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • QuintilesIMS Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Palantir Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments